source
- UK regulator suspends new patients from receiving Tavneos (Avacopan Vifor) amid data concernsThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has decided to stop prescribing Tavneos, known locally as Avacopan Vifor, to any new patients. The decision follows the regulator’…
- Fortrea acquires Worldwide Clinical Trials' early-phase division for $45 millionFortrea announced it will purchase the early-phase services division of Worldwide Clinical Trials for $45 million. The transaction gives Fortrea control of Worldwide's clinical pharmacology unit,…